From the Editor
The push to ban ED drugs from Medicare reimbursement isn't about their "lifestyle" classification.
Pharma has more in common with tobacco than it may think.
Sarah WealleansLandor Associates
Calendar of Events
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva